In-Person Access Only | 1.75 CE/CME Credits
The Cancer Updates Conference will consist of educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of gastrointestinal and breast cancers. Each agenda is comprised of presentations that will break down the most clinically relevant information applicable to community care. This dinner program will be hosted as an in-person event only.
Program Chairs
Brett Ecker, MD | RWJBarnabas Health
Deborah Toppmeyer, MD | Rutgers Cancer Institute
Program Speakers
Louise Ligresti, MD | RWJBarnabas Health
Kristen Spencer, DO | NYU Langone Health
Eleonora Teplinsky, MD | Valley Health System
Conference Agenda
Thursday, February 6, 2025
5:15 PM
Networking and Cocktails
5:30 PM
Welcome and Opening Remarks
5:35 PM
GI Cancer: Top Findings from ASCO GI Kristen Spencer, DO | NYU Langone Health
6:05 PM
Breast Cancer: Top Findings from SABCS Eleonora Teplinsky, MD | Valley Health System
6:25 PM
Dinner and Exhibits
6:45 PM
Non CME Session Presented by Pfizer
7:30 PM
Survivorship Louise Ligresti, MD | RWJBarnabas Health
7:50 PM
Panel Discussion Deborah Toppmeyer, MD | Rutgers Cancer Institute Brett Ecker, MD | RWJBarnabas Health Kristen Spencer, DO | NYU Langone Health Louise Ligresti, MD | RWJBarnabas Health Eleonora Teplinsky, MD | Valley Health System
8:30 PM
Adjourn
Agenda Subject To Change. All times are EST.
-
Review recent clinical advances in the treatment of gastrointestinal (GI) and breast cancers, with a focus on the most relevant data from recent studies and clinical trials.
Evaluate the role of emerging therapies in GI and breast cancer treatment, including new medications, targeted therapies, and immunotherapies.
Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.
Assess and manage side effects and toxicities associated with current and emerging therapies in GI and breast cancer patients.
Discuss multidisciplinary care approaches that enhance collaboration between oncologists, pharmacists, nurses, and advanced practitioners in treating GI and breast cancers.
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
-
Experience great local attendance in an environment designed for networking.
Network with top national key opinion leaders and community leaders.
Stand out with limited booths in a non-competitive environment.
Foster personal connections through exclusive one-on-one time with your targeted audience.